Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATR-258 for GRK-Biased Signaling in Human Skeletal Muscle
NCT07421024Phase 2Active, not recruiting
- Start
- Feb 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ATR-258 in obesity. Started Feb 2026; status: active, not recruiting.
02
Drugs
ATR-258
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07421024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07421024.